Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Bobrowicz M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Kusowska A
Subjects: Antigens, CD20*/Antigens, CD20*/Antigens, CD20*/immunology ; Antigens, CD20*/Antigens, CD20*/Antigens, CD20*/metabolism ; Antigens, CD20*/Antigens, CD20*/Antigens, CD20*/genetics
-
Source:
Oncoimmunology [Oncoimmunology] 2024 Jun 04; Vol. 13 (1), pp. 2362454. Date of Electronic Publication: 2024 Jun 04 (Print Publication: 2024).Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN:
Record details
-
Authors :
Hlavackova E; Department of Clinical Immunology and Allergology, St. Anne's University Hospital in Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University Brno, Czech Republic.
Subjects: Rituximab*/Rituximab*/Rituximab*/therapeutic use ; Rituximab*/Rituximab*/Rituximab*/administration & dosage; Humans
-
Source:
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia [Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub] 2024 Jun; Vol. 168 (2), pp. 167-176. Publisher: Vydavatelství Univerzity Palackého Country of Publication: Czech Republic NLM ID: 101140142 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Li W; Affiliation Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, China.; Chang Y
Subjects: Lymphoma, Mantle-Cell*/Lymphoma, Mantle-Cell*/Lymphoma, Mantle-Cell*/drug therapy ; Lymphoma, Mantle-Cell*/Lymphoma, Mantle-Cell*/Lymphoma, Mantle-Cell*/mortality ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use
-
Source:
Annals of hematology [Ann Hematol] 2024 Jun; Vol. 103 (6), pp. 2003-2012. Date of Electronic Publication: 2024 Feb 03.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
Record details
-
Authors :
Zieliński M; Department of Medical Immunology, Medical University of Gdańsk, Debinki 7 80-210, Poland; Poltreg S.A., Botaniczna 20 Street, 80-298 Gdańsk, Poland.
Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/immunology ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; T-Lymphocytes, Regulatory*/T-Lymphocytes, Regulatory*/T-Lymphocytes, Regulatory*/immunology
-
Source:
International immunopharmacology [Int Immunopharmacol] 2024 May 10; Vol. 132, pp. 111919. Date of Electronic Publication: 2024 Mar 30.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
Record details
-
Authors :
Yiğit Kaya S; Department of Hematology, Faculty of Medicine, Istanbul Medipol University, Turkey. Electronic address: .; Mutlu YG
Subjects: Leukemia, Hairy Cell*/Leukemia, Hairy Cell*/Leukemia, Hairy Cell*/drug therapy ; Leukemia, Hairy Cell*/Leukemia, Hairy Cell*/Leukemia, Hairy Cell*/pathology ; Vemurafenib*/Vemurafenib*/Vemurafenib*/administration & dosage
-
Source:
Leukemia research [Leuk Res] 2024 May; Vol. 140, pp. 107495. Date of Electronic Publication: 2024 Mar 29.Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
Record details
-
Authors :
Narváez J; Department of Rheumatology, Hospital Universitario de Bellvitge. Bellvitge Biomedical Research Institute (IDIBELL), Feixa Llarga, s/n, Hospitalet de Llobregat, 08907, Barcelona, Spain. .; Cañadillas E
Subjects: Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/drug therapy ; Rituximab*/Rituximab*/Rituximab*/therapeutic use ; Myositis*/Myositis*/Myositis*/drug therapy Antisynthetase syndrome
-
Source:
Arthritis research & therapy [Arthritis Res Ther] 2024 Jun 18; Vol. 26 (1), pp. 122. Date of Electronic Publication: 2024 Jun 18.Publisher: BioMed Central Country of Publication: England NLM ID: 101154438 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-6362
Record details
-
Authors :
Kato K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan. .; Izutsu K
Subjects: Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/drug therapy ; Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/diagnostic imaging ; Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/mortality
-
Source:
International journal of hematology [Int J Hematol] 2024 Jun; Vol. 119 (6), pp. 677-685. Date of Electronic Publication: 2024 Mar 22.Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
Record details
-
Authors :
Alping P; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Subjects: Rituximab*/Rituximab*/Rituximab*/therapeutic use ; Rituximab*/Rituximab*/Rituximab*/economics ; Multiple Sclerosis, Relapsing-Remitting*/Multiple Sclerosis, Relapsing-Remitting*/Multiple Sclerosis, Relapsing-Remitting*/drug therapy
-
Source:
Annals of neurology [Ann Neurol] 2024 Jun; Vol. 95 (6), pp. 1099-1111. Date of Electronic Publication: 2024 Mar 26.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7707449 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
Record details
